<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2448-8909</journal-id>
<journal-title><![CDATA[Medicina crítica (Colegio Mexicano de Medicina Crítica)]]></journal-title>
<abbrev-journal-title><![CDATA[Med. crít. (Col. Mex. Med. Crít.)]]></abbrev-journal-title>
<issn>2448-8909</issn>
<publisher>
<publisher-name><![CDATA[Colegio Mexicano de Medicina Crítica A.C.]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2448-89092017000100016</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Índice de Briones y delta de CO 2 como pronóstico en choque hipovolémico-traumático]]></article-title>
<article-title xml:lang="en"><![CDATA[Briones index and CO 2 delta as prognosis in hypovolemic traumatic shock]]></article-title>
<article-title xml:lang="pt"><![CDATA[Indíce de Briones e delta de CO 2 como prognóstico no choque hipovolêmico-traumático]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Mendoza Portillo]]></surname>
<given-names><![CDATA[Elizabeth]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Lozano Nuevo]]></surname>
<given-names><![CDATA[José Juan]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Mendoza Rodríguez]]></surname>
<given-names><![CDATA[Martín]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Hospital General La Villa  ]]></institution>
<addr-line><![CDATA[Ciudad de México ]]></addr-line>
<country>México</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Universidad Nacional Autónoma de México  ]]></institution>
<addr-line><![CDATA[Ciudad de México ]]></addr-line>
<country>Mexico</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>02</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>02</month>
<year>2017</year>
</pub-date>
<volume>31</volume>
<numero>1</numero>
<fpage>16</fpage>
<lpage>19</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S2448-89092017000100016&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S2448-89092017000100016&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S2448-89092017000100016&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen:  Antecedentes:  El choque hemorrágico conduce a la disminución del suministro de oxígeno, disminución de la perfusión tisular, hipoxia celular, daño celular, síndrome de disfunción multiorgánica y muerte. Está demostrado que existen diferentes escalas pronósticas y determinaciones bioquímicas que permiten identificar al paciente en riesgo.  Objetivo:  Establecer la correlación que existe entre el índice de Briones (IB), delta de CO2 (&#916;CO2) y la disfunción orgánica en pacientes con choque hipovolémico traumático.  Material y métodos:  Se realizó un estudio transversal, retrospectivo, comparativo y analítico; participaron 46 pacientes, se evaluaron variables demográficas, presión oncótica, IB, diferencia arteriovenosa de CO2, escalas pronósticas y seguimiento a 48 horas con puntos de desenlace: mortalidad y disfunción orgánica.  Resultados:  La distribución por género fue 41% mujeres y 59% hombres. La edad promedio: 38 ± 14.6 años. La clasificación del choque hipovolémico fue: clase I: 7%, clase II: 39%, clase III: 24%, clase IV: 30%; IB: 0.25 ± 0.07 mmHg, DB: -7.9 ± 5.2 mmol/L, lactato: 3.01 ± 2.2 mmol/L, &#916;CO2: 6.98 ± 4.6 mmHg. La mortalidad a las 48 horas: 10.8%. Trauma score: 9 ± 3 puntos; SOFA: 6 ± 3 puntos. Lesión renal aguda (LRA): 41%. &#916;CO2 &gt; 6 mmHg mostró sensibilidad 0.91 y especificidad 0.54 como predictor de mortalidad, se identificó el mejor punto de corte &gt; 10.5 mmHg (0.96 y 0.98 respectivamente, p &lt; 0.001, intervalo de confianza IC 0.988-1.0; área bajo la curva ABC 0.998).  Conclusiones:  Este estudio demostró que &#916;CO2 es un marcador con impacto en la mortalidad y escalas pronósticas de SOFA y trauma score. El IB puede emplearse como pronóstico en pacientes que desarrollarán LRA dentro de las primeras 48 horas de estancia en la Unidad de Cuidados Intensivos (UCI) con una adecuada significancia estadística.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract:  Background: Hemorrhagic shock leads to decrease in oxygen supply, decreased tissue perfusion, cellular hypoxia, cell damage, multiple organ dysfunction syndrome and death. It is shown that there are different prognostic scales and biochemical determinations that identify the patient at risk.  Aim:  To establish the correlation between the Briones index, &#916;CO2 and organ dysfunction in patients with traumatic hypovolemic shock.  Material and methods:  A transversal, retrospective, comparative and analytical study; from January 2015 to May 2016, involving 46 patients diagnosed with traumatic hypovolemic shock who were admitted to the intensive care unit of the General Hospital La Villa. We evaluated demographic variables, oncotic presion, Briones index, arteriovenous difference of CO2. We prognostic and monitoring 48 hours with descenlace points: mortality and organic dysfunction.  Results:  Of the 46 study participants represented gender: female 41%, men 59%. The average age: 38 ± 14.6 years. Hypovolemic shock classification based deficit represented: class I: 7%, class II: 39%, class III: 11 24%, class IV: 30%; IB: 0.25 ± 0.07 mmHg, DB: -7.9 ± 5.2 mmol/L, lactate: 3.01 ± 2.2 mmol/L, &#916;CO2: 6.98 ± 4.6 mmHg. Mortality at 48 hours: was 10.8%. Trauma score 9 ± 3 points; SOFA: 6 ± 3 points. Acute kidney injury (AKI) occurred in 41%. &#916;CO2 &gt; 6 mmHg showed sensitivity 0.91 and specificity 0.54 as a predictor of mortality, the highest cutpoint 10.5 mmHg was identified with 0.96 and 0.98 respectively (p &lt; 0.001, confidence interval IC 0.988-1.0; area under the curve AUC 0.998).  Conclusions:  This study showed that &#916;CO2 is a marker with impact on mortality and prognostic scales and Trauma SOFA score. The IB can be used as a prognostic in patients who developed Acute kidney injury (AKI) within the first 48 hours of stay in the ICU with adequate statistical significance.]]></p></abstract>
<abstract abstract-type="short" xml:lang="pt"><p><![CDATA[Resumo:  Antecedentes:  O choque hemorrágico conduz à uma diminuição do suprimento de oxigênio, diminuição da perfusão tecidual, hipóxia celular, danos às células, síndrome de disfunção de múltiplos órgãos e morte. Está demonstrado que há diferentes escalas de prognóstico e determinações bioquímicas que identificam o paciente em risco.  Objetivo:  Estabelecer a correlação entre o índice de Briones (IB), Delta do CO2(&#916;CO2) e disfunção orgânica em pacientes com choque hipovolêmico traumático.  Material e métodos:  Estudo transversal, retrospectivo, comparativo e analítico; paticiparam 46 pacientes, foram avaliadas variáveis demográficas, pressão oncótica, IB, diferença artério-venosa de CO2, escalas de prognóstico e monitorização às 48 horas com os resultados: disfunção de múltiplos órgãos e mortalidade.  Resultados:  O gênero representou: sexo feminino (41%), sexo masculino (59%). Idade média: 38 ± 14.6 anos. A classificação do choque hipovolêmico foi: classe I: 7%, classe II: 39%, classe III: 24%, classe IV: 30%; IB: 0.25 ± 0.07 mmHg, DB: -7.9 ± 5.2 mmol/L, lactato: 3.01 ± 2.2 mmol/L, &#916;CO2: 6.98 ± 4.6mmHg. A mortalidade às 48 horas: 10.8%. Trauma score: 9 + 3 pontos; SOFA: 6 ± 3 pontos. LRA: 41%. &#916;CO2 &gt; 6 mmHg mostrou sensibilidade 0.91 e especificidade 0.54 como preditor de mortalidade, se identificou uma coorte &gt; 10.5 mmHg (0.96 e 0.98, respectivamente, p 0.001, intervalo de confiança IC 0.988-1.0; área sob a curva ABC 0.998).  Conclusões: Este estudo demonstrou que &#916;CO2 é um marcador com impacto na mortalidade e nas escalas de prognóstico SOFA e Trauma score. O IB pode ser usado como um prognóstico em pacientes que desenvolveram LRA nas primeiras 48 horas de internação na UTI com uma adequada significância estatística.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Choque hipovolémico]]></kwd>
<kwd lng="es"><![CDATA[trauma]]></kwd>
<kwd lng="es"><![CDATA[presión oncótica]]></kwd>
<kwd lng="es"><![CDATA[delta CO2]]></kwd>
<kwd lng="es"><![CDATA[índice de Briones]]></kwd>
<kwd lng="en"><![CDATA[Hypovolemic shock]]></kwd>
<kwd lng="en"><![CDATA[trauma]]></kwd>
<kwd lng="en"><![CDATA[oncotic pressure]]></kwd>
<kwd lng="en"><![CDATA[CO2 delta]]></kwd>
<kwd lng="en"><![CDATA[Briones index]]></kwd>
<kwd lng="pt"><![CDATA[Choque hipovolêmico]]></kwd>
<kwd lng="pt"><![CDATA[trauma]]></kwd>
<kwd lng="pt"><![CDATA[pressão oncótica]]></kwd>
<kwd lng="pt"><![CDATA[delta CO2]]></kwd>
<kwd lng="pt"><![CDATA[índice de Briones]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bécquer]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Aguila]]></surname>
<given-names><![CDATA[PC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Shock hipovolémico]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Caballero-López]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Bécquer-García]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Domínguez-Perera]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Acosta-Armas]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Castro-Expósito]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Martínez-Peralta]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<source><![CDATA[Terapia intensiva]]></source>
<year>2008</year>
<edition>2</edition>
<page-range>178-201</page-range><publisher-loc><![CDATA[La Habana ]]></publisher-loc>
<publisher-name><![CDATA[Editorial Ciencias Médicas]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Johansson]]></surname>
<given-names><![CDATA[PI]]></given-names>
</name>
<name>
<surname><![CDATA[Stensballe]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Effect of Haemostatic Control Resuscitation on mortality in massively bleeding patients a before and after study]]></article-title>
<source><![CDATA[Vox Sang]]></source>
<year>2009</year>
<volume>96</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>111-8</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Guly]]></surname>
<given-names><![CDATA[HR]]></given-names>
</name>
<name>
<surname><![CDATA[Bouamra]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
</person-group>
<source><![CDATA[Transfusion of blood products in trauma]]></source>
<year>2011</year>
<volume>45</volume>
<page-range>34-9</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fraga]]></surname>
<given-names><![CDATA[GP]]></given-names>
</name>
<name>
<surname><![CDATA[Bansal]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Coimbra]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Transfusion of blood products in trauma an update]]></article-title>
<source><![CDATA[J Emerg Med]]></source>
<year>2010</year>
<volume>39</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>253-60</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mutschler]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Nienaber]]></surname>
<given-names><![CDATA[U]]></given-names>
</name>
<name>
<surname><![CDATA[Brockamp]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Wafaisade]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Wyen]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Peiniger]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A critical reappraisal of the ATLS classification of hypovolaemic shock does it really reflect clinical reality?]]></article-title>
<source><![CDATA[Resuscitation]]></source>
<year>2013</year>
<volume>84</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>309-13</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kaminski]]></surname>
<given-names><![CDATA[MV]]></given-names>
</name>
<name>
<surname><![CDATA[Haase]]></surname>
<given-names><![CDATA[TJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Albumin and colloid osmotic pressure implications for fluid resuscitation]]></article-title>
<source><![CDATA[Crit Care Clin]]></source>
<year>1992</year>
<volume>8</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>311-21</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Díaz de León]]></surname>
<given-names><![CDATA[PM]]></given-names>
</name>
<name>
<surname><![CDATA[Reyes]]></surname>
<given-names><![CDATA[NV]]></given-names>
</name>
<name>
<surname><![CDATA[Sánchez]]></surname>
<given-names><![CDATA[VEC]]></given-names>
</name>
<name>
<surname><![CDATA[Cruz]]></surname>
<given-names><![CDATA[LC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[La presión coloidosmótica como índice de supervivencia]]></article-title>
<source><![CDATA[Rev Asoc Mex Med Crit Ter Int]]></source>
<year>1987</year>
<volume>3</volume>
<page-range>11-4</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
